Julie Schmidt
Contact information
Colleges
Julie Schmidt
Postdoctoral epidemiologist
Julie Schmidt is an epidemiologist whose primary research interest is in the role of modifiable risk factors in the aetiology of cancer. Her current work focuses on the relationship between metabolite profile and prostate cancer risk and on understanding how metabolite profile may be associated with dietary, hormonal, lifestyle and genetic factors. For these studies, large-scale prospective cohort data are utilised; this includes data from the European Prospective Investigation into Cancer and Nutrition (EPIC) and the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group (EHNBPCCG).
Julie joined the Cancer Epidemiology Unit in 2012 as a statistical epidemiologist. Later she started her doctoral studies in the same unit and obtained her DPhil on the ‘Epidemiology of Metabolite Profile and Prostate Cancer Risk’ in 2018. Before joining the unit, she studied Clinical Nutrition (BSc, VIA University College, Denmark, 2005-2009) and Health Science (MSc, Aarhus University, Denmark, 2010-2012).
Recent publications
-
Comparison of Major Protein-Source Foods and Other Food Groups in Meat-Eaters and Non-Meat-Eaters in the EPIC-Oxford Cohort.
Journal article
Papier K. et al, (2019), Nutrients, 11
-
Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: a prospective study of 3057 matched case-control sets from EPIC.
Journal article
Schmidt JA. et al, (2019), Int J Cancer
-
Vegetarian diets and risk of hospitalisation or death with diabetes in British adults: results from the EPIC-Oxford study.
Journal article
Papier K. et al, (2019), Nutr Diabetes, 9
-
Reproductive factors, exogenous hormone use and risk of B-cell non-Hodgkin lymphoma in a cohort of women from the European Prospective Investigation into Cancer and Nutrition.
Journal article
Costas L. et al, (2018), Am J Epidemiol
-
Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort.
Journal article
Sarink D. et al, (2018), BMC Cancer, 18